Nuclear medicine applications to the neuroimaging of AIDS. A neuroradiologist's perspective.
The human immunodeficiency virus (HIV) responsible for AIDS is reaching epidemic proportions in the United States and Europe. As new therapeutic modalities against HIV are uncovered and applied to treat prophylactically asymptomatic and therapeutically symptomatic HIV positive patients, imaging studies are no longer used just to characterize the organic-morphologic effects of HIV and opportunistic infections and neoplasms. This article discusses the current applications and contribution of nuclear medicine to the management of neurologically symptomatic HIV-positive patients.
Ruiz
A
A
Department of Radiology, University of Miami School of Medicine, Florida, USA.
Post
J D
JD
Ganz
W I
WI
Georgiou
M
M
D015526:AIDS Dementia Complex / Q000000981:diagnostic imaging* / Q000517:prevention & control / Q000628:therapy; D017088:AIDS-Related Opportunistic Infections / Q000000981:diagnostic imaging; D001921:Brain / Q000000981:diagnostic imaging*; D001927:Brain Diseases / Q000000981:diagnostic imaging / Q000821:virology; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000821:virology; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging / Q000821:virology; D004196:Disease Outbreaks; D018792:Encephalitis, Viral / Q000000981:diagnostic imaging; D005060:Europe; D015658:HIV Infections / Q000517:prevention & control / Q000628:therapy; D006801:Humans; D011871:Radiology; D011877:Radionuclide Imaging; D014481:United States